Novel heterocyclic compounds of the formula (I) in which R1, R2, R3, R4 and D have the meanings indicated in Claim 1, are activators of glucokinase and can be used for the prevention and/o treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy.
化学式(I)中R1、R2、R3、R4和D的含义如权利要求书中所示的新型
杂环化合物是
葡萄糖激酶的激活剂,可用于预防和/或治疗糖尿病1型和2型、肥胖症、神经病和/或肾病。